Analysis of Brain Tumors Using Matrix Assisted Laser Desorption/Ionization Mass Spectrometry
NCT00592709 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84
Last updated 2021-02-21
Summary
We are collecting brain tissue specimens and blood samples from patients at Vanderbilt University Medical Center who are undergoing intracranial surgery to remove brain tissue, including brain tumors, tissue from epilepsy surgery and brain tissue removed during surgery for other non-cancerous types of brain tissus. These specimens will then be studied using a novel microscopic laser-directed protein mass spectrometric analysis, looking for unique protein signatures.
Conditions
- Brain Diseases
Sponsors & Collaborators
-
Vanderbilt University Medical Center
lead OTHER
Principal Investigators
-
Reid C. Thompson, MD · Vanderbilt University Medical Center, Department of Neurological Surgery
Eligibility
- Min Age
- 2 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-05-31
- Primary Completion
- 2010-12-31
- Completion
- 2012-12-31
Countries
- United States
Study Locations
More Related Trials
-
Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer Using Pathology Biopsies
NCT06387979 ·Status: SUSPENDED
-
Study of Stored Tumor Samples in Young Patients With Brain Tumors
NCT00897286 ·Status: TERMINATED
-
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
NCT00870129 ·Status: RECRUITING ·Phase: NA
-
Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
NCT06090903 ·Status: RECRUITING ·Phase: NA
-
Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
NCT00005083 ·Status: WITHDRAWN ·Phase: PHASE2
-
High Resolution Magnetic Resonance Imaging in Patients With Brain Tumors
NCT02035852 ·Status: COMPLETED
-
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
NCT00967200 ·Status: COMPLETED
-
Risk Factors for Adult-Onset Brain Tumors
NCT00592865 ·Status: TERMINATED
-
Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors
NCT00005790 ·Status: WITHDRAWN ·Phase: NA
-
Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument
NCT05171127 ·Status: COMPLETED
-
A Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research Purposes
NCT01251913 ·Status: TERMINATED
-
Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma
NCT04540107 ·Status: RECRUITING ·Phase: PHASE1
-
AI-assisted Diagnosis of Malignant Brain Tumors
NCT07198256 ·Status: RECRUITING
-
Biomarkers for Prognosis of Glioblastoma (GBM)
NCT01493219 ·Status: COMPLETED
-
Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors
NCT05982691 ·Status: RECRUITING
-
Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)
NCT03067467 ·Status: RECRUITING
-
Spectroscopic Magnetic Resonance Imaging of Glioma
NCT03677999 ·Status: WITHDRAWN
-
Investigational Imaging Technique During Brain Surgery
NCT05513859 ·Status: SUSPENDED ·Phase: NA
-
Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
NCT05756985 ·Status: RECRUITING
-
Evaluation of 3D Ultrasound in Brain Tumor Surgery
NCT05956977 ·Status: UNKNOWN ·Phase: NA
-
Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology
NCT00330109 ·Status: UNKNOWN ·Phase: NA
-
PET (FDG)-MR Imaging for the Adult Patients Presented With Brain Tumor
NCT02071017 ·Status: UNKNOWN
-
Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
NCT02379572 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma
NCT00005082 ·Status: COMPLETED ·Phase: NA
-
Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy
NCT03952598 ·Status: SUSPENDED ·Phase: PHASE2